Your shopping cart is currently empty

PD 168568, an orally active and potent dopamine receptor D4 (DRD4) antagonist featuring an isoindolinone structure, demonstrates selective affinity for the D4 receptor over D2 and D3 receptors, with K i values of 8.8, 1842, and 2682 nM, respectively. This compound is utilized in glioblastoma (GBM) research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $1,980 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $2,500 | 1-2 weeks | 1-2 weeks |
| Description | PD 168568, an orally active and potent dopamine receptor D4 (DRD4) antagonist featuring an isoindolinone structure, demonstrates selective affinity for the D4 receptor over D2 and D3 receptors, with K i values of 8.8, 1842, and 2682 nM, respectively. This compound is utilized in glioblastoma (GBM) research. |
| Targets&IC50 | D3 receptor:2682 nM (Ki), D4 Receptor:8.8 nM (Ki), D2 Receptor:1842 nM (Ki) |
| Molecular Weight | 349.47 |
| Formula | C22H27N3O |
| Cas No. | 210688-56-5 |
| Smiles | C(CN1CCN(CC1)C2=CC(C)=C(C)C=C2)C3C=4C(C(=O)N3)=CC=CC4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.